News

Weight-loss craze sparks a DC lobbying bonanza
President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...
Eli Lilly stock gets a rare downgrade: what is HSBC concerned about?
HSBC analyst warns of a downside in Eli Lilly stock to $700. Rajesh Kumar cited 'valuation' as his number 1 concern.
Stocktwits on MSN1h
Eli Lilly Stock Gets A Double Downgrade And Price Target Cut By HSBC Over Valuation, Competition Concerns
HSBC on Monday double downgraded Eli Lilly and Co. (LLY) stock to ‘Reduce’ from ‘Buy’ and also lowered its price target to ...
Decreased Appetite, Controlled Cravings, Mild Nausea & More: What Do Patients On Mounjaro Feel?
Approved by India’s apex drug regulatory body, the weight-loss drug is a once-weekly injection priced at Rs 4,375 for a 5 mg ...
Stocktwits on MSN4h
Novo Nordisk’s Weight-Loss Drug Wegovy Launched In Thailand, Marks Entry Into Southeast Asia
Novo Nordisk (NVO) has launched its weight-loss drug Wegovy in Thailand, Reuters reported on Monday, citing an executive of ...
Mounjaro side effects revealed: Decreased appetite, mild nausea and more
Mounjaro, the new weight loss drug, is gaining popularity in India for its rapid results. Patients report better appetite control, blood sugar management, and significant weight loss.
Devdiscourse7h
Novo Nordisk's Wegovy Makes a Splash in Thailand's Weight-Loss Market
Novo Nordisk has launched its popular weight-loss drug Wegovy in Thailand, marking its first entry into the Southeast Asian ...
Congress is back. What’s next for Medicaid?
A key House committee is being tasked with finding $880 billion of those cuts, most of which would likely come from Medicaid.